Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc. - Wikidata - wikimedia - TriplyDB

Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc.

Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc.

http://www.wikidata.org/entity/Q34273793

about

Clinical utility of RapidArc™ radiotherapy technology.Post-operative radiation therapy Volumetric modulated arc therapy: a review of current literature and clinical use in practice.Treating lung cancer with dynamic conformal arc therapy: a dosimetric study Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments.Planning analysis for locally advanced lung cancer: dosimetric and efficiency comparisons between intensity-modulated radiotherapy (IMRT), single-arc/partial-arc volumetric modulated arc therapy (SA/PA-VMAT).Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer Volumetric modulated arc therapy for treatment of solid tumors: current insights.Dosimetric accuracy and clinical quality of Acuros XB and AAA dose calculation algorithm for stereotactic and conventional lung volumetric modulated arc therapy plans.Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations.Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy.Oncogene addiction and radiation oncology: effect of radiotherapy with photons and carbon ions in ALK-EML4 translocated NSCLC.Improvement of conformal arc plans by using deformable margin delineation method for stereotactic lung radiotherapy.Dosimetric comparison between IMRT and VMAT in irradiation for peripheral and central lung cancer.On the role of the optimization algorithm of RapidArc(®) volumetric modulated arc therapy on plan quality and efficiency.Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case report.

P2860

Q26773193-CE076A42-8CE1-475A-B04C-CE87A1770CF8 Q26830376-B63CD3F2-D221-440C-97D8-2CA5F2B7D78D Q30461426-F848FBD2-C84B-4869-9EBB-1B6F25DC8421 Q33759703-C4425681-EA08-4B81-984B-B4F815514F92 Q34231941-A9581B2B-CBD2-49F9-86D0-899C8B4AEAD3 Q35232033-8733A44F-37B3-4B42-9D84-39813F49949A Q35521009-38937F01-0C78-4131-9D92-EC691ECC7B51 Q35815373-B0882497-08F9-46CD-AD55-0C459F0D0045 Q37194294-BD6DD401-8D53-4B18-9846-4AE0F52ECD6D Q38631481-28279174-6752-4E32-BF6B-70498E5FB7CF Q42085382-94409D9C-BC91-48EA-B105-021740D51BD5 Q42608693-0B350E01-AA9C-4D94-B067-BD3F40DBF404 Q43677664-A3CB6D80-8D3D-4997-B74A-16D30EC19177 Q47204412-23575299-E775-4410-9D58-F100F05ED338 Q50016239-2DDAACD8-F199-474D-B76F-42E01FA10FE1 Q50233738-0FA7EFA1-51C4-4166-9DBB-CFF8C46070BC Q50670378-FBAE3D45-871E-4161-BFFB-21F0D50625C5 Q54940866-96C65EBB-16DC-4F36-BFDD-2D4AEF1F0608

P2860

Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc.

http://www.wikidata.org/entity/Q34273793

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Large volume unresectable loca ...... utcome results with rapid arc.

@ast

Large volume unresectable loca ...... utcome results with rapid arc.

@en

Large volume unresectable loca ...... utcome results with rapid arc.

@nl

type

label

Large volume unresectable loca ...... utcome results with rapid arc.

@ast

Large volume unresectable loca ...... utcome results with rapid arc.

@en

Large volume unresectable loca ...... utcome results with rapid arc.

@nl

prefLabel

Large volume unresectable loca ...... utcome results with rapid arc.

@ast

Large volume unresectable loca ...... utcome results with rapid arc.

@en

Large volume unresectable loca ...... utcome results with rapid arc.

@nl

P1433

Q34273793-AE2FCAFB-DB33-471D-A586-8EA6B8D55DC7

P1476

Q34273793-15F20D76-B219-47E7-B442-0CAED7339D67

P2093

Q34273793-0ADA5CB7-05E8-4074-9B7F-07306C831CCF

Q34273793-17032B0D-E58D-4E76-B97A-4B97202D4225

Q34273793-17631AE0-ABC5-4E6B-92CD-2A0FB596EA01

Q34273793-65C0E1A3-B75D-41A5-BE0C-00E1344EF225

Q34273793-7C44F2AE-8AF7-4C38-8257-4F8F743F40F4

Q34273793-81EB6F78-7486-42FC-8D82-A4ABB11FB76A

Q34273793-9710E6D9-00CA-43C7-A0C0-3F6BF21EFB93

Q34273793-9C6EB251-E34C-46AF-8BA3-2E88702DEF0C

Q34273793-CA800BC8-4D22-47CB-AA4F-F8D7F7758E03

Q34273793-ED518C78-F798-477B-8F19-D44290AEB71A

P2860

Q34273793-10D4910B-5B2A-487E-BAD7-6B82DFC93D63

Q34273793-11F34D37-B65D-41DD-B02C-F8A4EA6D36D9

Q34273793-2BEABABF-B71B-428E-B3E7-1B53846ACB19

Q34273793-350ACEB6-F382-4F1D-AA1C-4CFB0CA86E92

Q34273793-3C237D6F-E7C8-4C45-BF58-17182D04DB6E

Q34273793-3FDADC7D-7030-443C-A990-E1076BE5ADC2

Q34273793-42EDCEBA-77CC-462B-8480-18A329B28B3B

Q34273793-6626D66F-197E-4722-98F9-9DFD67C7B995

Q34273793-6AAD6916-5A42-466D-B3C3-1E224ADB8EFD

Q34273793-704A798C-6B92-4CD1-B422-90A9A904D2F5

P2888

Q34273793-B8F2F9E6-9DA2-4E25-B6D4-2AA5FF969195

P304

Q34273793-A1CB885E-4A48-4C47-9D31-6CBF69BD42AF

P31

Q34273793-E2BB18FC-4AB9-4693-A3F9-92F8D83CAD8C

P356

Q34273793-FC4618D9-B15C-4274-A5E3-EE9CB679BA1F

P478

Q34273793-9537A664-6ED1-4D23-AC23-151B1739B5AA

P577

Q34273793-9D836BE5-C28F-4C15-BE33-850A5538013D

P6179

Q34273793-6C190EB6-4302-4F66-9B23-9950B60595FF

P698

Q34273793-51BF94EE-4104-403D-97F5-B0BBB9000C8A

P932

Q34273793-B7B5C97D-B953-4E42-B209-163C3BEB6FB4

P356

P1433

Radiation Oncology

P1476

Large volume unresectable loca ...... utcome results with rapid arc.

@en

P2093

Angelo Tozzi

http://www.w3.org/2001/XMLSchema#string

Antonella Fogliata

http://www.w3.org/2001/XMLSchema#string

Armando Santoro

http://www.w3.org/2001/XMLSchema#string

Filippo Alongi

http://www.w3.org/2001/XMLSchema#string

Luca Cozzi

http://www.w3.org/2001/XMLSchema#string

Marta Scorsetti

http://www.w3.org/2001/XMLSchema#string

Pierina Navarria

http://www.w3.org/2001/XMLSchema#string

Pietro Mancosu

http://www.w3.org/2001/XMLSchema#string

Raffaele Cavina

http://www.w3.org/2001/XMLSchema#string

Sara Pentimalli

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.

Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience.

Early clinical experience of radiotherapy of prostate cancer with volumetric modulated arc therapy

Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience

Reduction in radiation dose to lung and other normal tissues using helical tomotherapy to treat lung cancer, in comparison to conventional field arrangements.

The GLAaS algorithm for portal dosimetry and quality assurance of RapidArc, an intensity modulated rotational therapy

Toxicity report of a phase 1/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy.

A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy.

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.

P2888

P304

94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-5-94

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027636479

http://www.w3.org/2001/XMLSchema#string

P698

20950469

http://www.w3.org/2001/XMLSchema#string

P932

2972299

http://www.w3.org/2001/XMLSchema#string